Idamakanti M, Bijjam RI, Kumar M, Mukkamalla SK. Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review. J Med Cases [Internet]. 2025 Jan. 1 [cited 2026 Jan. 22];16(6):212-21. Available from: https://jmc.elmerpub.com/index.php/jmc/article/view/5136